A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

Clinical trial NCT02690142 · COMPLETED

Trial details

NCT number: NCT02690142
Sponsor: Affibody
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Psoriasis Healthy Subjects

Start date: 2016-02-01
Primary completion: 2018-01-10
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.